Research Tracker›Biomarker Atlas›Marker Pages›Resistin

Resistin across conditions

Resistin appears in 2 entries of the OSMF biomarker atlas, covering Long COVID, ME/CFS. Across those entries it is elevated in 1, mixed in 1. Because the same marker shifts in several unrelated conditions, it is best understood as a signal of shared biology such as inflammation, vascular or metabolic stress rather than as a condition-specific test. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Long COVIDME/CFS

Where Resistin is reported

Also listed as: Adipokine

ConditionDirectionCompared againstAssociated symptomsSource
Long COVID↑ elevatedhealthy controlsInsulin resistance, inflammationLai et al. 2023
ME/CFS↕ inconsistenthealthy controlsMetabolic inflammationStrawbridge et al. 2019

Frequently asked questions

In which conditions is Resistin altered?

In the OSMF atlas Resistin is reported in Long COVID, ME/CFS. It is elevated in 1, mixed in 1 across 2 entries.

Does Resistin point to one specific diagnosis?

No. Because Resistin changes in several conditions (Long COVID, ME/CFS), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.

What is the LOINC code for Resistin?

Entries in this atlas use LOINC 42702-4. LOINC codes identify the laboratory observation so results can be compared across systems.

Is one abnormal Resistin result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Resistin across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/resistin.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.